Early and sustained increase in time in range 1 year after initiation of hybrid close loop therapy via telemedicine in type 1 diabetes patients.
Journal Information
Full Title: Acta Diabetol
Abbreviation: Acta Diabetol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestAMG reports speaker fees from Novo Nordisk, Sanofi, Elli Lilly, Boehringer Ingelheim, Abbott and Medtronic. DCH reports speaker fees from Novo Nordisk, Sanofi, Medtronic and Abbott. Ethical Standard StatementThe protocol was approved by the ethics and research committee of the Pontificia Universidad Javeriana and the Hospital Universitario San Ignacio. Informed consentAll patients filled out informed consent. Conflict of interest AMG reports speaker fees from Novo Nordisk, Sanofi, Elli Lilly, Boehringer Ingelheim, Abbott and Medtronic. DCH reports speaker fees from Novo Nordisk, Sanofi, Medtronic and Abbott."
"Funding Open Access funding provided by Colombia Consortium."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025